KRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
KORU Medical Systems, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$3.02+0.02 (+0.67%)
Close on Oct 19, 2026
- Market cap
- $149.52M
- P/E (TTM)
- –
- Dividend yield
- –
KORU Medical Systems statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| Market Cap | $139.44M | $229.23M |
| Enterprise Value | $131.15M | $194.73M |
| PS Ratio | 3.09 | 3.14 |
| PB Ratio | 7.72 | 3.19 |
| P/TBV Ratio | 8.51 | 4.69 |
| P/FCF Ratio | 179.54 | 27.25 |
| P/OCF Ratio | 100.25 | 22.23 |
Enterprise value
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| EV / Sales | 2.91 | 2.93 |
| EV / FCF | 168.87 | 27.85 |
Income (trailing twelve months)
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| Revenue | $45.11M | $102.39M |
| Gross Profit | $28.16M | $60.36M |
| Operating Income | -$1.65M | -$4.31M |
| Pretax Income | -$1.81M | -$2.26M |
| Net Income | -$1.82M | -$6.57M |
| EBITDA | -$861.50K | -$1.98M |
| EPS (Diluted) | $0.00 | -$0.07 |
Margins
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| Gross Margin | 62.4% | 55.1% |
| Operating Margin | -3.66% | -6.04% |
| Pretax Margin | -4.01% | -4.11% |
| Profit Margin | -4.03% | -10.5% |
| EBITDA Margin | -1.91% | -2.67% |
| FCF Margin | 1.72% | -0.30% |
Returns
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| Return on Equity (ROE) | -10.5% | -19.2% |
| Return on Assets (ROA) | -6.80% | -13.3% |
| Return on Invested Capital (ROIC) | -14.3% | -4.11% |
| Return on Capital Employed (ROCE) | -7.95% | -9.07% |
Growth
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 22.4% | 8.85% |
| Revenue Growth (3Y CAGR) | 13.8% | 7.08% |
| Revenue Growth (5Y CAGR) | 11.2% | 11.8% |
Balance sheet
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $8.29M | $37.33M |
| Net Cash (Debt) | $8.29M | $3.92M |
| Net Cash Per Share | $0.18 | $0.28 |
| Equity (Book Value) | $18.05M | $57.36M |
| Book Value Per Share | $0.39 | $2.81 |
| Tangible Book Value | $16.39M | $10.71M |
| Working Capital | $12.33M | $54.64M |
Financial position
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| Current Ratio | 2.72 | 2.50 |
| Quick Ratio | 1.85 | 1.54 |
Cash flow (trailing twelve months)
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| Operating Cash Flow | $1.39M | -$653.46K |
| Capital Expenditures | -$614.34K | -$3.69M |
| Free Cash Flow | $776.65K | -$835.02K |
| FCF Per Share | $0.02 | -$0.02 |
Efficiency
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| Asset Turnover | 1.69 | 0.59 |
| Inventory Turnover | 4.01 | 2.21 |
| Revenue Per Employee | $617.91K | $322.75K |
| Profits Per Employee | -$24.92K | -$52.11K |
| Employee Count | 73 | 197 |
Dividends and yields
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| Earnings Yield | -1.30% | -6.92% |
| FCF Yield | 0.56% | -0.62% |
Shares
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| Shares Outstanding | 46,171,900 | 44,856,700 |
| Shares Change (YoY) | 2.49% | 3.35% |
| Shares Change (QoQ) | 0.03% | 0.27% |
| Float | 38,103,400 | 36,934,400 |
| Shares Held by Insiders | 17.5% | 10.6% |
| Shares Held by Institutions | 44.5% | 63.5% |
Scores
| Measure | KORU Medical Systems | Industry median |
|---|---|---|
| Altman Z-Score | 8.76 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -2.94 | -2.64 |
Calculated by StockData from KORU Medical Systems's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.